Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 606-612

  Kim, Hyun Young ^a   Kim, Nayoung ^a,b   Kang, Jung Mook ^b   Park, Young Soo ^a,b   Lee, Dong Ho ^a,b   Kim, Yu Rim ^a   Kim, Joo Sung ^b   Jung, Hyun Chae ^b   Song, Sung ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Atrophic gastritis; Helicobacter pylori; Pepsinogen

Indexed keywords

IMMUNOGLOBULIN G; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENDER; GROUPS BY AGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; KOREA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEX DIFFERENCE; SMOKING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CLINICAL ENZYME TESTS; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MASS SCREENING; MIDDLE AGED; PEPSINOGENS; PROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 67649655938     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283086757     Document Type: Article

References (38)

1. Samloff IM, Vans K, lhamaki T, Siurala M, Rotter Jl. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology: a study in relatives of patient with pernicious anemia. Gastroenterolog. 1982; 83:204-209.
2. Kimura K.Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscop. 1969; 1:87-97.
3. Sitas F, Smallwood R, Jewell D, Millard PR, Newell DG, Meuwissen SG, et al. Serum anti-Helicobacter pylor. IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomaikers Pre. 1393; 2:119-123.
4. Nameteita T, Miki K, Kimmey M, Fritsche T, Hughe D, Suzuki K. Chronic atrophic: gastritis and Helicobacter pylor. infection among Japanese- Americans in Seattle. Am J Epidemio. 2000; 151:820-830.
5. Yaraaji- Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse) background of Helicobacter pylor. antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001; 49:335-340.
6. Kodoi A, Yoshihara M, Sumii K, Haruma K, Kajiyama G. Serum pepsinogen in screening for gastric caner. J Gastroentero. 1995; 30:452-460.
7. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroentero. 2003; 98:735-739.
8. Kitahara F, Kabayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gu. 1999;44:693-697.
9. Schlemper PJ, Van der Werf SD, Vandenbroucke JP, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch working populations:evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gu. 1995; 37:199-204.
10. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999-2001; first result using the national cancer incidence database. Cancer Res Trea. 2005; 37:325-331.
11. Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylor. infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroentero. 2003; 38:332-338.
12. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric cance. 2006; 9:245-253.
13. Kim JH, Kim HY, Kim NY, Kim SW, Kim JG, Kim JJ, et al. Seroepidemiological study of Helicobacter pylor. infection in asymptomatic people in South Korea. J Gastroenterol Hepato. 2001; 16:969-975.
14. Kim SY, Ahn JS, Ha YJ, Doh HJ, Jang MH, Chung SI, et al. Serodiagnosis of Helicobacter pylor. infection in Korean patients using enzyme-linked immunosorbent assay. J Immunoassa. 1998; 19:251-270.
15. Kang JM, Kim NY, Yoo JY, Park YS, Lee DH, Kim HY. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacte. 2008; 13:146-156.
16. Serrano MT, Lanas Al, Lorente S, Sainz R. Cytokine effects on pepsinogen secretion from human peptic cells. Gu. 1997; 40:42-48.
17. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylor. stimulates pepsinogen secretion from isolated human peptic cells. Gu. 2002; 50:13-18.
18. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori t. serum pepsinogen in an asymptomatic Japanese population. Gastroenterolog. 1998; 102:760-766.
19. Webb PM, Hengels KJ, Moller H, Newell DG, Palli D, Elder JB, et al. The epidemiology of lower serum pepsinogen A levels and an international association with gastric cancer rates. Gastroenterolog. 1994; 107: 1335-1344.
20. Wagner S, Haruma K, Gladziwa U, Soudah B, Gebel M, Bleck S, et al. Helicobacter pylor. infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroentero. 1994; 89: 1211-1218.
21. Knight T, Greaves S, Wilson A, Hengels K, Newell D, Corlett M, et al. Variability in serum pepsinogen levels in an asymptomatic population. Eur J Gastroenterol Hepato. 1995; 7:647-654.
22. Kikuchi S, Inaba Y, Wada O, Miki K, Tenjin H, Kaneko E, et al. The association of smoking and drinking habits with serum pepsinogens. Int J Epidemio. 1995; 24:346-353.
23. Denda K, Fujibayashi S, Seko C, Nakamura K, Ehata Y, Yagami T. Relationship between factors examined at health examination and serum pepsinogen levels in healthy adults. Nippon Koshu Eisei Zassh. 1998; 45:336-342.
24. So JB, Yeoh KG, Moochala S, Chachlani N, Ho J, Wong WK, et al. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylor. infection: a prospective study. Gastric cance. 2002; 5:228-232.
25. Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, et al. Normal serum pepsinogen I levels in adults: A population-based study with special reference to Helicobacter pylor. infection and parietal cell antibodies. Scand J Clic Lab Inves. 2005; 65:291-300.
26. Di Mario F, Cavallaro LG, Moussa AM, Caruana P, Merli R, Maini A, et al. Usefulness of serum pepsinogens in Helicobacter pylor. chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sc. 2006; 51:1791-1795.
27. Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, et al. Serologic markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroentero. 2004; 99:1910-1915.
28. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterolog. 1995; 108:917-924.
29. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroentero. 1989; 24:870-876.
30. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroentero. 1998; 93:1090-1096.
31. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi- Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepato. 2003; 15:885-891.
32. Kuipers EJ. Relationship between Helicobacter pylor., atrophic gastritis and gastric cancer. Aliment Pharmacol The. 1998; 12:25-36.
33. Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Re. 1993; 84:1086-1090.
34. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraund F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cance. 2003; 88:1239-1247.
35. Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, et al. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Digestive Di. 2004; 5:22-27.
36. Kim NY, Lee HS, Choi Bl, Kim CY. Diagnostic significance of ALT follow-up for the patients with chronic liver disease with elevated serum a-fetoprotein level (above 400 ng/ml) and no mass lesion in the liver in ultrasonogram. Korean J Gastroentero. 1993; 25:503-511.
37. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, et al. Seroprevalence of Helicobacter pylor. in South Korea. Helicobacte. 2007; 12:333-340.
38. Kang HY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylor. out of the gastric mucosa. Dig Dis Sc. 2006; 51:2310-2315.